Captisol, Brought to you by Ligand

Captisol, a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY (remdesivir), KYPROLIS (carfilzomib) and most recently Lasix ONYU (furosemide), helps solubilize, stabilize and enhance the bioavailability of difficult to deliver molecules. Developed by CyDex Pharmaceuticals, a Ligand company, Captisol is the leading pharmaceutical-grade sulfobutylether beta cyclodextrin (SBECD) with a strong record of safety, reliability and consistency.

Captisol has been utilized clinically across several routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation and dermal. Companies are increasingly exploring the benefits of Captisol in consumer health, supplements and personal care products.

quick proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.